logo
  Join        Login             Stock Quote

Becton, Dickinson (BDX) Closes Purchase Of Safety Syringes

 December 26, 2012 09:55 AM
 


(By Balaseshan) Medical devices maker Becton, Dickinson and Co. (NYSE: BDX) said it has closed its acquisition of California-based privately-held Safety Syringes Inc., which specializes in the development of anti-needlestick devices for prefilled syringes, for undisclosed sum.

The company expects the transaction to be minimally dilutive for fiscal year 2013, and does not expect it to impact BD's previously communicated 2013 earnings guidance.

The acquisition broadens BD's healthcare worker safety offering to include passive safety technologies for any prefillable syringe customer.

"We believe the Safety Syringes product line is a valuable asset to BD and aligns well with our focus on healthcare worker safety, and offering higher-value products. We are excited about this acquisition, which expands its presence in safety technologies and further demonstrates BD's commitment to developing innovative solutions that help address our customers' unmet needs," said Claude Dartiguelongue, President, BD Medical - Pharmaceutical Systems.

[Related -3 Styles Of Successful Dividend Investing]

BD is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and general public. Its operations consist of 3 business segments: BD Medical, BD Diagnostics and BD Biosciences.

BDX is trading down 0.43% at $78.22 on Wednesday. The stock has been trading between $71.56 and $80.56 for the past 52 weeks.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageThinking Clearly About Forecasting

There’s a pernicious rumor making the rounds that economic and market forecasts are accurate. There’s also read on...

article imageThe Fed Concerned About Importing Disinflation

The latest Reuters poll is showing 24 out of 43 economists projecting the first rate hike in the US by June read on...

article imageClearing Up Bond Trading

How far do regulators’ rule proposals go for improving transparency for bond read on...

article imageThe Unnecessary $2 Trillion Global Stimulus Economic Benefit Concert

The G-20’s vague, unlikely-to-materialize stimulus plan is nice sounding, yet read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.